A guide to the benefits of CAR-T immunotherapy
Intended for healthcare professionals
Opinion Previous     Next

A guide to the benefits of CAR-T immunotherapy

Pavan Amara Nurse, midwife and health journalist

Nurses can have a key role to play in the patient journeys for people given chimeric antigen receptor T-cell therapy

Chimeric antigen receptor T-cell therapy, known as CAR-T or CAR T-cell therapy, is a relatively new form of immunotherapy that can be used to treat some cancers. During CAR-T therapy, which became available in the UK in 2018, a person’s immune system cells are collected and reprogrammed to target cancer.

Cancer Nursing Practice. 22, 6, 14-15. doi: 10.7748/cnp.22.6.14.s6

Want to read more?

Already have access? Log in


3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics

Alternatively, you can purchase access to this article for the next seven days. Buy now

Are you a student? Our student subscription has content especially for you.
Find out more